Replies to post #88646 on Biotech Values

[DewDiligence]

Thanks for the update. I had forgotten about the 2008 PR you replied to, which was unusually disingenuous for a company of FRX’s prominence.

[genisi]

FRX announced positive top-line results of ATTAIN, a six month double-blind placebo-controlled pivotal Phase III study comparing the efficacy and safety of inhaled aclidinium bromide 200µg and 400µg twice daily (BID) versus placebo, in 828 patients with moderate to severe COPD.

http://www.frx.com/news/PressRelease.aspx?ID=1512675